Clinical Trials Directory

Trials / Completed

CompletedNCT01519362

A Woman Suffered From Leukocytopenia and Widespread Migration After Polyacrylamide Hydrogel (PAAG) Injection in Epicranial Aponeurosis

Status
Completed
Phase
Study type
Observational
Enrollment
1 (actual)
Sponsor
Duo Zhang · Academic / Other
Sex
Female
Age
50 Years – 50 Years
Healthy volunteers
Not accepted

Summary

Polyacrylamide hydrogel (PAAG) has been used as an injectable filler for soft tissue augmentation in different parts of the body , such as face, breast , or even penis for more than a decade . However, there are never reports about the application of a large amount of PAAG in epicranial aponeurosis to change the contour of the upper cranium accompanied with leukocytopenia. This fancy application turned out to be a disaster for the women who suffered from leukocytopenia , widespread migration of PAAG, recurrent swelling of the affected tissues and temporal pain changing with the temperature and the facial expression .

Conditions

Timeline

Start date
2011-10-01
First posted
2012-01-26
Last updated
2012-01-26

Source: ClinicalTrials.gov record NCT01519362. Inclusion in this directory is not an endorsement.